Don’t miss the latest developments in business and finance.

Alembic Pharma USFDA

Premium

Alembic Pharma gets tentative nod from USFDA for diabetes management drug

The product is therapeutically equivalent to Synjardy tablets of Boehringer Ingelheim Pharmaceuticals, Inc

Updated On: 20 Jul 2020 | 12:04 PM IST

Premium

FDA new drug approval run rate down in FY20 for most Indian pharma majors

According to analysts, companies are skeptical about entering crowded opportunities

Updated On: 31 May 2020 | 1:56 PM IST

Premium

Alembic Pharma rises 3% as JV firm successfully completes USFDA inspection

The inspection was carried out from January 6 to January 8.

Updated On: 09 Jan 2020 | 10:27 AM IST

Alembic Pharma gets USFDA nod for neuropathic pain management drug

The approved product is therapeutically equivalent to the reference listed drug Lyrica Capsules

Updated On: 22 Jul 2019 | 12:47 PM IST

Alembic Pharma gets USFDA nod for solution to treat allergic conjunctivitis

The company said it currently has 83 ANDA approvals from USFDA

Updated On: 10 Dec 2018 | 2:33 PM IST

Premium

Alembic Pharma gains 5% on successful USFDA inspection of Panelav facility

The stock was up 5% at Rs 527 on the BSE in early morning trade after the company informed that the successful USFDA inspection at its API facility at Panelav with zero 483s.

Updated On: 24 Apr 2018 | 9:37 AM IST

Alembic Pharma gets USFDA nod for bladder drug

The approved product is equivalent to Enablex of Allergan Pharmaceuticals

Updated On: 12 Dec 2017 | 1:21 PM IST